Research involving the vulnerable sick raises difficult challenges for investigators and Institutional Review Boards. Exactly who among the ill counts as vulnerable is a matter of judgement, and involves consideration of susceptibility to harm and capacity to provide free and informed consent. A balanced approach is required when protections are considered, and the benefits as well as the risks of research participation must be carefully weighed. A variety of protections for the vulnerable sick in research are available, including enrolling subjects in a study only with a strong justification, ensuring that consent is free and comprehending, and setting limits on the risk to which they may be asked to endure. Discussion of three contemporary controversies, placebo-controlled trials in the psychiatric setting, phase I clinical trials and oncology patients, and emergency room research involving patients incapable of giving consent, highlights the little recognized prominence of risk-benefit issues in the clinical studies in the vulnerable sick
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
References found in this work BETA
No references found.
Citations of this work BETA
Respect for Human Vulnerability: The Emergence of a New Principle in Bioethics.Henk ten Have - 2015 - Journal of Bioethical Inquiry 12 (3):395-408.
The Ethical Analysis of Risk.Charles Weijer - 2000 - Journal of Law, Medicine & Ethics 28 (4):344-361.
I Need a Placebo Like I Need a Hole in the Head.Charles Weijer - 2002 - Journal of Law, Medicine & Ethics 30 (1):69-72.
Similar books and articles
Lessons From Everyday Lives: A Moral Justification for Acute Care Research.Andrew D. McRae & Charles Weijer - unknown
Protecting and Respecting the Vulnerable: Existing Regulations or Further Protections?Stephanie R. Solomon - 2013 - Theoretical Medicine and Bioethics 34 (1):17-28.
The Limits of Consent: A Socio-Ethical Approach to Human Subject Research in Medicine.Oonagh Corrigan (ed.) - 2009 - Oxford University Press.
Which Benefits of Research Participation Count as 'Direct'?Alexander Friedman, Emily Robbins & David Wendler - 2012 - Bioethics 26 (2):60-67.
U.S. Federal Regulations for Emergency Research: A Practical Guide and Commentary.Andrew McRae & Charles Weijer - unknown
When Are Research Risks Reasonable in Relation to Anticipated Benefits?Charles Weijer & Paul B. Miller - unknown
Bioethics for Clinicians: 10. Research Ethics.Charles Weijer, Bernard Dickens & Eric M. Meslin - unknown
Mental Capacity, Good Practice and the Cyclical Consent Process in Research Involving Vulnerable People.R. Norman, D. Sellman & C. Warner - 2006 - Clinical Ethics 1 (4):228-233.
Vulnerable Populations in Research: The Case of the Seriously Ill.Philip J. Nickel - 2006 - Theoretical Medicine and Bioethics 27 (3):245-264.
Are Phase 1 Trials Therapeutic? Risk, Ethics, and Division of Labor.James A. Anderson & Jonathan Kimmelman - 2014 - Bioethics 28 (3):138-146.
Protecting the Vulnerable: Autonomy and Consent in Health Care.Margaret Brazier & Mary Lobjoit (eds.) - 1991 - Routledge.
Ethics in Qualitative Research: 'Vulnerability', Citizenship and Human Rights.Pamela Fisher - 2012 - Ethics and Social Welfare 6 (1):2-17.
Added to index2010-09-08
Total downloads14 ( #334,802 of 2,172,819 )
Recent downloads (6 months)1 ( #324,903 of 2,172,819 )
How can I increase my downloads?